Teleflex Incorporated (NYSE:TFX) Director Stephen K. M.D. Klasko sold 200 shares of the stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $241.88, for a total transaction of $48,376.00. Following the transaction, the director now owns 8,080 shares of the company’s stock, valued at $1,954,390.40. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Shares of Teleflex Incorporated (TFX) opened at 246.08 on Thursday. The company has a 50-day moving average of $226.68 and a 200 day moving average of $208.75. Teleflex Incorporated has a 52 week low of $136.53 and a 52 week high of $246.67. The firm has a market capitalization of $11.08 billion, a P/E ratio of 47.06 and a beta of 1.07.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, August 3rd. The medical technology company reported $2.04 EPS for the quarter, topping the consensus estimate of $1.91 by $0.13. The company had revenue of $528.60 million during the quarter, compared to the consensus estimate of $518.98 million. Teleflex had a net margin of 12.36% and a return on equity of 16.12%. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.89 earnings per share. Equities research analysts anticipate that Teleflex Incorporated will post $8.28 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, September 15th. Stockholders of record on Tuesday, August 15th were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.55%. The ex-dividend date was Friday, August 11th. Teleflex’s payout ratio is presently 26.00%.

WARNING: “Stephen K. M.D. Klasko Sells 200 Shares of Teleflex Incorporated (TFX) Stock” was first posted by Watch List News and is owned by of Watch List News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this report can be read at https://www.watchlistnews.com/stephen-k-m-d-klasko-sells-200-shares-of-teleflex-incorporated-tfx-stock/1609982.html.

Several large investors have recently bought and sold shares of the company. Toronto Dominion Bank increased its position in shares of Teleflex by 14.5% during the second quarter. Toronto Dominion Bank now owns 552 shares of the medical technology company’s stock worth $115,000 after acquiring an additional 70 shares in the last quarter. Archford Capital Strategies LLC boosted its holdings in Teleflex by 29,025.0% during the second quarter. Archford Capital Strategies LLC now owns 1,165 shares of the medical technology company’s stock worth $217,000 after purchasing an additional 1,161 shares during the last quarter. Cookson Peirce & Co. Inc. purchased a new position in Teleflex during the second quarter worth about $11,813,000. Advisory Services Network LLC boosted its holdings in Teleflex by 933.8% during the second quarter. Advisory Services Network LLC now owns 827 shares of the medical technology company’s stock worth $172,000 after purchasing an additional 747 shares during the last quarter. Finally, Koch Industries Inc. boosted its holdings in Teleflex by 47,174.3% during the second quarter. Koch Industries Inc. now owns 959,669 shares of the medical technology company’s stock worth $955,000 after purchasing an additional 957,639 shares during the last quarter. 89.75% of the stock is owned by institutional investors.

A number of equities analysts have recently commented on the stock. Leerink Swann upgraded shares of Teleflex from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $227.00 to $266.00 in a research note on Thursday, September 7th. Zacks Investment Research downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Thursday, August 31st. Jefferies Group LLC restated a “buy” rating and set a $230.00 price objective on shares of Teleflex in a research note on Thursday, August 3rd. KeyCorp restated a “hold” rating on shares of Teleflex in a research note on Wednesday, September 6th. Finally, BidaskClub downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $260.75.

About Teleflex

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Insider Buying and Selling by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.